VERTEX PHARMACEUTICALS INC / MA EPS (Basic) 2008-2025 | VRTX
What is eps (basic)?
Basic earnings per share (EPS) can be defined as net income divided by the weighted average number of common shares outstanding during a period.
What is VERTEX PHARMACEUTICALS INC / MA's current eps (basic)?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual eps (basic) for 2025 was $15.46, a 843.27% increase from 2024. VERTEX PHARMACEUTICALS INC / MA eps (basic) for the quarter ending September 30, 2025 was $4.24.
What was VERTEX PHARMACEUTICALS INC / MA's eps (basic) in 2024?
VERTEX PHARMACEUTICALS INC / MA annual eps (basic) for 2024 was $-2.08, a 114.80% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's eps (basic) in 2023?
VERTEX PHARMACEUTICALS INC / MA annual eps (basic) for 2023 was $14.05, a 8.33% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year eps (basic) CAGR?
VERTEX PHARMACEUTICALS INC / MA eps (basic) grew at a compound annual growth rate (CAGR) of 8.17% from FY2020 to FY2025, going from $10.44 to $15.46 over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $15.46 | +843.3% | 10-K |
| FY2024 | $-2.08 | -114.8% | 10-K |
| FY2023 | $14.05 | +8.3% | 10-K |
| FY2022 | $12.97 | +42.7% | 10-K |
| FY2021 | $9.09 | -12.9% | 10-K |
| FY2020 | $10.44 | +127.9% | 10-K |
| FY2019 | $4.58 | -44.4% | 10-K |
| FY2018 | $8.24 | +677.4% | 10-K |
| FY2017 | $1.06 | +330.4% | 10-K |
| FY2016 | $-0.46 | +80.1% | 10-K |
| FY2015 | $-2.31 | +26.4% | 10-K |
| FY2014 | $-3.14 | -58.6% | 10-K |
| FY2013 | $-1.98 | -296.0% | 10-K |
| FY2012 | $-0.50 | -457.1% | 10-K |
| FY2011 | $0.14 | +103.7% | 10-K |
| FY2010 | $-3.77 | -1.6% | 10-K |
| FY2009 | $-3.71 | -13.5% | 10-K |
| FY2008 | $-3.27 | - | 10-K |